Akash Tewari
Stock Analyst at Jefferies
(0.63)
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ARVN Arvinas | Downgrades: Hold | 52 10 | 7.22 | 38.5% | 3 | May 2, 2025 | |
BMY Bristol-Myers Squibb | Maintains: Buy | 70 68 | 46.52 | 46.17% | 4 | Apr 23, 2025 | |
BMRN Biomarin Pharmaceuti... | Initiates Coverage On: Outperform | 95 | 53.99 | 75.96% | 2 | Nov 15, 2024 | |
BNTX BioNTech | Upgrades: Buy | 96 150 | 102.71 | 46.04% | 3 | Sep 17, 2024 | |
RLAY Relay Therapeutics | Upgrades: Buy | 11 16 | 3.17 | 404.73% | 3 | Sep 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 177 189 | 126.65 | 49.23% | 2 | Aug 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 80 | 17.36 | 360.83% | 2 | Jul 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 29 75 | 37.55 | 99.73% | 1 | Jul 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 994 1015 | 767.31 | 32.28% | 6 | Jun 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 42 50 | 28.97 | 72.59% | 5 | Apr 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 37 75 | 40.85 | 83.6% | 4 | Mar 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 31 | 14.52 | 113.5% | 1 | Dec 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 935 937 | 511.57 | 83.16% | 4 | Nov 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 12 | n/a | n/a | 2 | Nov 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 38 39 | 23.88 | 63.32% | 2 | Oct 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 49 18 | 7.02 | 156.41% | 2 | Aug 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 497 513 | 538.53 | -4.74% | 2 | Jul 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 3.65 | 393.15% | 1 | Jun 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 125 | 79.45 | 57.33% | 1 | Mar 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 8 11 | 12.4 | -11.29% | 1 | Dec 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 30 4 | 5.42 | -33.58% | 2 | Dec 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 17 | 1.17 | 1352.99% | 1 | Dec 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 6 4 | n/a | n/a | 2 | Nov 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 68 69 | n/a | n/a | 3 | Aug 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 75 | 32.35 | 131.84% | 2 | Oct 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 151 | 280.41 | -46.15% | 1 | Oct 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 28 | 44.21 | -36.67% | 2 | Oct 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 180 | n/a | n/a | 2 | Oct 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 107 | n/a | n/a | 1 | Mar 12, 2021 |